0930 ET - Humana tells analysts on its 1Q call that medical costs are running in line with its expectations and the impact of federal billing rule changes is also playing out as predicted. The company says it had no update on its closely-watched litigation aimed at fixing a huge expected decline in quality-related Medicare bonuses. Humana said it is still aiming to achieve a 3% margin on its core business in 2027. Humana is up 6% in early trading. (anna.mathews@wsj.com)
(END) Dow Jones Newswires
April 30, 2025 09:30 ET (13:30 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.